Aldehyde Scavenging Compounds for Toxicity Mitigation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments lack effective solutions for reducing or preventing diseases and disorders associated with aldehyde toxicity, which are implicated in various pathological conditions such as Age-Related Macular Degeneration, inflammatory ocular conditions, skin disorders, and neurodegenerative diseases.
Innovation Solution
Development of specific compounds, represented by Compound A, in various salt forms and free base forms, which are administered to scavenge toxic aldehydes, thereby reducing their accumulation and mitigating the severity of associated diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used, then existing therapeutic options are available, but they fail to effectively reduce or prevent diseases associated with aldehyde toxicity
Solution Approach 1:
The patent describes a single compound (Compound A) that can scavenge multiple different toxic aldehydes including malondialdehyde, 4-hydroxyl-2-nonenal, glyoxal, and methylglyoxal. This universal scavenging capability allows one compound to treat diverse pathological conditions such as age-related macular degeneration, inflammatory ocular conditions, skin disorders, and neurodegenerative diseases, all of which involve aldehyde toxicity but differ in specific aldehyde types and disease mechanisms.
2Object-affected harmful factors
If no specific aldehyde scavenging compound is administered, then existing therapies can be maintained, but toxic aldehydes continue to accumulate and cause tissue damage
Solution Approach 1:
The patent employs Compound A to convert the harmful effect of toxic aldehydes into a beneficial outcome. The compound selectively reacts with and neutralizes toxic aldehydes such as malondialdehyde and 4-hydroxyl-2-nonenal that would otherwise cause protein cross-linking, DNA damage, and cellular dysfunction. By transforming these harmful reactive aldehydes into non-toxic adducts, the compound eliminates their damaging effects while maintaining physiological function.
3Ease of operation
If Compound A is administered in multiple salt forms, then solubility and bioavailability are improved, but formulation complexity increases
Solution Approach 1:
The patent describes Compound A in multiple salt forms including hydrochloride, mesylate, tosylate, and trifluoroacetate salts, each with different solubility and bioavailability characteristics. By varying the counterion parameter, the compound can be optimized for different administration routes and patient needs. For example, more soluble salts may be preferred for oral administration while less soluble forms may be suitable for topical or injectable formulations, allowing flexible dosing and improved patient compliance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively treat and prevent conditions linked to aldehyde toxicity by scavenging toxic aldehydes, thereby reducing their harmful effects on tissues and organs, offering a therapeutic approach for diverse pathological conditions.
Implementation Method 1
compounds acting as a scavenger for toxic aldehydes... effectively treat and prevent conditions linked to aldehyde toxicity by scavenging toxic aldehydes
Data Source
AI summary
The present invention relates to free-base and salt forms, and compositions thereof of small molecule therapeutics acting as a scavenger for toxic aldehydes. The present invention further relates to use of the free-base and salt forms, and compositions thereof for treating diseases, disorders, or conditions in which aldehyde toxicity is implicated in their pathogenesis.